Salesforce shares dip on soft revenue outlook as Agentforce grows

Salesforce (NYSE: CRM) reported first-quarter fiscal results and then issued guidance for the following quarter that fell marginally short of Street estimates, prompting a pullback in the stock. The company posted roughly $11.1 billion in revenue for the quarter ended April 30 and non-GAAP EPS of $3.88, while guiding Q2 revenue to $11.27–11.35 billion versus an LSEG consensus near $11.36 billion. Market reaction reflected concern that near-term growth may be softer than investors had hoped.

The quarter showed clear momentum in Salesforce’s AI portfolio: combined Agentforce and Data 360 annual recurring revenue (ARR) reached nearly $3.4 billion, with Agentforce ARR reported at about $1.2 billion. Management highlighted accelerating adoption—several thousand paid deals and billions of agentic work units delivered—which demonstrates traction for autonomous-agent applications even as the business remains a minority of total revenue today. These operational metrics underscore progress in monetizing AI capabilities but also explain why investors are scrutinizing near-term revenue guidance.

The immediate market impact was a continuation of a year-to-date decline in Salesforce shares and increased volatility in software names broadly. Reuters and other outlets noted that the stock had experienced significant drawdowns earlier in the year, as investors reassessed how quickly incumbents can monetize AI without compressing license economics. That reassessment has driven a cautious tone across the sector.

In a wider context, the software industry faces a transition risk where advanced AI tools from large model providers may alter enterprise spending patterns—shifting budgets toward infrastructure or consumption-based contracts and away from some legacy per-seat products. The pace at which vendors like Salesforce adapt pricing and packaging, and demonstrate durable ROI for customers, will be critical to long-term growth trajectories.

Analysts say the coming quarters will be decisive: if Agentforce and Data 360 convert trials into sustainable, high-margin ARR at scale, Salesforce’s growth outlook could re-accelerate. Conversely, if AI adoption cannibalizes seat-based revenue or slows contract expansion, multiples and sentiment may remain pressured. Investors will watch guidance cadence, large deal momentum and margin conversion closely for signs of durable progress.